Standout Papers

Ranibizumab for Neovascular Age-Related Macular Degeneration 2001 2026 2009 2017 4.5k
  1. Ranibizumab for Neovascular Age-Related Macular Degeneration (2006)
    Philip J. Rosenfeld, David M. Brown et al. New England Journal of Medicine
  2. Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration (2006)
    David M. Brown, Peter K. Kaiser et al. New England Journal of Medicine
  3. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration (2012)
    Jeffrey S. Heier, David M. Brown et al. Ophthalmology
  4. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study (2008)
    David M. Brown, Mark Michels et al. Ophthalmology
  5. Size-Dependent Proinflammatory Effects of Ultrafine Polystyrene Particles: A Role for Surface Area and Oxidative Stress in the Enhanced Activity of Ultrafines (2001)
    David M. Brown, Martin Wilson et al. Toxicology and Applied Pharmacology
  6. Structural-functional relationships in diabetic nephropathy. (1984)
    S. Michael Mauer, Michael W. Steffes et al. Journal of Clinical Investigation
  7. Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1 (2008)
    Carl D. Regillo, David M. Brown et al. American Journal of Ophthalmology
  8. Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials (2013)
    David M. Brown, Quan Dong Nguyen et al. Ophthalmology
  9. Relationship between Optical Coherence Tomography–Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema (2006)
    David J. Browning, Adam R. Glassman et al. Ophthalmology
  10. Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration (2013)
    Brandon Busbee, Allen C. Ho et al. Ophthalmology
  11. Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study (2011)
    David M. Brown, Peter A. Campochiaro et al. Ophthalmology

Immediate Impact

7 by Nobel laureates 4 from Science/Nature 133 standout
Sub-graph 1 of 15

Citing Papers

Age-Related Macular Degeneration
2024 Standout
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Standout
27 intermediate papers

Works of David M. Brown being referenced

Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
2006 Standout
and 9 more

Author Peers

Author Last Decade Papers Cites
David M. Brown 1333 3667 12855 10112 159 22.2k
David M. Brown 944 2439 8409 6331 289 14.9k
Jeong Hun Kim 389 4190 2418 1606 409 10.8k
Xiang Li 1597 4253 3275 4537 591 14.8k
Nicholas L. Mills 2185 2039 190 2726 352 19.4k
Young Hee Yoon 219 936 4308 2864 202 6.8k
Alberto Izzotti 369 4529 1794 714 253 8.9k
Andreas Daiber 1079 6118 235 553 383 21.9k
Gang Liu 314 1431 571 495 331 8.8k
Thomas J. McDonald 1921 1773 467 213 313 13.3k
Wen Li 619 5793 552 323 451 11.6k

All Works

Loading papers...

Rankless by CCL
2026